Short- and Long-term Patient-reported Outcomes of Subcutaneous Implantable Cardioverter-defibrillator Therapy: Results from the RHYTHM DETECT Registry

Overview

Journal Heart Rhythm O2

Date 2024 Aug 9

PMID 39119026

Authors

Antonio Bisignani

Silvana De Bonis

Pietro Palmisano

Valter Bianchi

Domenico Pecora

Gianfranco Tola

Gerardo Nigro

Fabrizio Caravati

Giuseppe Mascia

Roberto Rordorf

Pasquale Notarstefano

Marco Polselli

Stefano Bianchi

Mariolina Lovecchio

Sergio Valsecchi

Andrea Droghetti

Affiliations

Soon will be listed here.

References

Breivik H, Borchgrevink P, Allen S, Rosseland L, Romundstad L, Hals E . Assessment of pain. Br J Anaesth. 2008; 101(1):17-24. DOI: 10.1093/bja/aen103. View

Quast A, Baalman S, Betts T, Boersma L, Bonnemeier H, Boveda S . Rationale and design of the PRAETORIAN-DFT trial: A prospective randomized CompArative trial of SubcutanEous ImplanTable CardiOverter-DefibrillatoR ImplANtation with and without DeFibrillation testing. Am Heart J. 2019; 214:167-174. DOI: 10.1016/j.ahj.2019.05.002. View

Migliore F, Viani S, Ziacchi M, Ottaviano L, Francia P, Bianchi V . The "Defibrillation Testing, Why Not?" survey. Testing of subcutaneous and transvenous defibrillators in the Italian clinical practice. Int J Cardiol Heart Vasc. 2022; 38:100952. PMC: 8761693. DOI: 10.1016/j.ijcha.2022.100952. View

Francia P, Biffi M, Adduci C, Ottaviano L, Migliore F, De Bonis S . Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study. Europace. 2020; 22(12):1822-1829. DOI: 10.1093/europace/euaa231. View

Vicentini A, Bisignani G, De Vivo S, Viani S, Savarese G, Francia P . Patient acceptance of subcutaneous versus transvenous defibrillator systems: A multi-center experience. J Cardiovasc Electrophysiol. 2021; 33(1):81-89. DOI: 10.1111/jce.15297. View

Pedersen S, Carter N, Barr C, Scholten M, Lambiase P, Boersma L . Quality of life, depression, and anxiety in patients with a subcutaneous versus transvenous defibrillator system. Pacing Clin Electrophysiol. 2019; 42(12):1541-1551. DOI: 10.1111/pace.13828. View

Carroll D, Hamilton G . Quality of life in implanted cardioverter defibrillator recipients: the impact of a device shock. Heart Lung. 2005; 34(3):169-78. DOI: 10.1016/j.hrtlng.2004.10.002. View

Droghetti A, Basso Ricci E, Scimia P, Harizai F, Marini M . Ultrasound-guided serratus anterior plane block combined with the two-incision technique for subcutaneous ICD implantation. Pacing Clin Electrophysiol. 2018; 41(5):517-523. DOI: 10.1111/pace.13318. View

Humphreys N, Lowe R, Rance J, Bennett P . Living with an implantable cardioverter defibrillator: The patients' experience. Heart Lung. 2015; 45(1):34-40. DOI: 10.1016/j.hrtlng.2015.10.001. View

10.

Botto G, Ziacchi M, Nigro G, DOnofrio A, Dello Russo A, Francia P . Intermuscular technique for implantation of the subcutaneous implantable defibrillator: a propensity-matched case-control study. Europace. 2023; 25(4):1423-1431. PMC: 10105850. DOI: 10.1093/europace/euad028. View

11.

Marshall P, Ketchell A, Maclean J . Comparison of male and female psychological outcomes related to implantable cardioverter defibrillators (COMFORTID). Eur J Cardiovasc Nurs. 2011; 11(3):313-21. DOI: 10.1016/j.ejcnurse.2011.06.010. View

12.

Rordorf R, Casula M, Pezza L, Fortuni F, Sanzo A, Savastano S . Subcutaneous versus transvenous implantable defibrillator: An updated meta-analysis. Heart Rhythm. 2020; 18(3):382-391. DOI: 10.1016/j.hrthm.2020.11.013. View

13.

DOnofrio A, Pieragnoli P, Biffi M, Nigro G, Migliore F, Francia P . Subcutaneous implantable cardioverter defibrillator implantation: An analysis of Italian clinical practice and its evolution. Int J Cardiol. 2018; 272:162-167. DOI: 10.1016/j.ijcard.2018.07.139. View

14.

Healey J, Krahn A, Bashir J, Amit G, Philippon F, McIntyre W . Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations : A Randomized, Multicenter Trial. Ann Intern Med. 2022; 175(12):1658-1665. DOI: 10.7326/M22-1566. View

15.

Sears S, Harrell R, Crozier I, Murgatroyd F, Boersma L, Manlucu J . Patient-reported quality of life and acceptance of the extravascular implantable cardioverter-defibrillator: Results from pivotal study. J Cardiovasc Electrophysiol. 2023; 35(2):240-246. DOI: 10.1111/jce.16151. View

16.

Ziacchi M, Bisignani G, Palmisano P, Scalone A, Martignani C, Elvira Mocavero P . Serratus anterior plane block in subcutaneous implantable cardioverter defibrillator implantation: A case-control analysis. J Cardiovasc Electrophysiol. 2019; 31(1):144-149. DOI: 10.1111/jce.14293. View

17.

Migliore F, Mattesi G, De Franceschi P, Allocca G, Crosato M, Calzolari V . Multicentre experience with the second-generation subcutaneous implantable cardioverter defibrillator and the intermuscular two-incision implantation technique. J Cardiovasc Electrophysiol. 2019; 30(6):854-864. PMC: 6850019. DOI: 10.1111/jce.13894. View

18.

Sandhu U, Kovacs A, Nazer B . Psychosocial symptoms of ventricular arrhythmias: Integrating patient-reported outcomes into clinical care. Heart Rhythm O2. 2022; 2(6Part B):832-839. PMC: 8710626. DOI: 10.1016/j.hroo.2021.09.011. View

19.

Frydensberg V, Johansen J, Moller S, Stromberg A, Pedersen S . Psychometric evaluation of the implantable cardioverter defibrillator body image concerns questionnaire (ICD-BICQ). J Cardiovasc Electrophysiol. 2021; 32(8):2295-2311. DOI: 10.1111/jce.15122. View

20.

Burns J, Serber E, Keim S, Sears S . Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey. J Cardiovasc Electrophysiol. 2005; 16(4):384-90. DOI: 10.1046/j.1540-8167.2005.40134.x. View